Publication

Translational Research in Sjögren’s Syndrome

Vissink, A., Spijkervet, F. K. L., Kroese, F. G. M. & Bootsma, H., 18-Jun-2018, Translational Oral Health Research. Meurman, J. H. (ed.). 1 ed. Springer International Publishing, p. 123-141 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

APA

Vissink, A., Spijkervet, F. K. L., Kroese, F. G. M., & Bootsma, H. (2018). Translational Research in Sjögren’s Syndrome. In J. H. Meurman (Ed.), Translational Oral Health Research (1 ed., pp. 123-141). Springer International Publishing. https://doi.org/10.1007/978-3-319-78205-8_10

Author

Vissink, Arjan ; Spijkervet, Fred K. L. ; Kroese, Frans G.M. ; Bootsma, Hendrika. / Translational Research in Sjögren’s Syndrome. Translational Oral Health Research. editor / Jukka H. Meurman. 1. ed. Springer International Publishing, 2018. pp. 123-141

Harvard

Vissink, A, Spijkervet, FKL, Kroese, FGM & Bootsma, H 2018, Translational Research in Sjögren’s Syndrome. in JH Meurman (ed.), Translational Oral Health Research. 1 edn, Springer International Publishing, pp. 123-141. https://doi.org/10.1007/978-3-319-78205-8_10

Standard

Translational Research in Sjögren’s Syndrome. / Vissink, Arjan; Spijkervet, Fred K. L.; Kroese, Frans G.M.; Bootsma, Hendrika.

Translational Oral Health Research. ed. / Jukka H. Meurman. 1. ed. Springer International Publishing, 2018. p. 123-141.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Vancouver

Vissink A, Spijkervet FKL, Kroese FGM, Bootsma H. Translational Research in Sjögren’s Syndrome. In Meurman JH, editor, Translational Oral Health Research. 1 ed. Springer International Publishing. 2018. p. 123-141 https://doi.org/10.1007/978-3-319-78205-8_10


BibTeX

@inbook{b60b153f1e6a462cb5f4c0cadf9b133d,
title = "Translational Research in Sj{\"o}gren’s Syndrome",
abstract = "Sj{\"o}gren’s syndrome (SS) is an autoimmune inflammatory disorder of the exocrine glands, particularly affecting lacrimal and salivary glands. Hallmark symptoms are dry mouth and dry eye, often in conjunction with general symptoms, such as malaise and fatigue. Lymphomas could develop in 5–10{\%} of the patients. As SS is a rather complex syndrome with many features, the one patient being diagnosed with SS may suffer from a different complex of complaints than another SS patient and may thus be in need of a different treatment approach. To better classify SS patients and to personalize their treatment, many clinicians and researchers are currently working on efforts (1) to refine classification of SS patients, (2) to ease the diagnostic work-up of SS, and (3) to better understand the etiopathogenesis of SS. Latter knowledge is essential to understand the course of the disease. This way clinicians will be able to identify patients who are at risk of developing SS or lymphomas; can intervene at an early stage of the disease to prevent damage to, e.g., the glands; as well as can personalize treatment with, e.g., biologicals. In this chapter, current major achievements are discussed, and promising new directions are indicated.",
author = "Arjan Vissink and Spijkervet, {Fred K. L.} and Kroese, {Frans G.M.} and Hendrika Bootsma",
year = "2018",
month = "6",
day = "18",
doi = "10.1007/978-3-319-78205-8_10",
language = "English",
isbn = "978-3-319-78204-1",
pages = "123--141",
editor = "Meurman, {Jukka H. }",
booktitle = "Translational Oral Health Research",
publisher = "Springer International Publishing",
edition = "1",

}

RIS

TY - CHAP

T1 - Translational Research in Sjögren’s Syndrome

AU - Vissink, Arjan

AU - Spijkervet, Fred K. L.

AU - Kroese, Frans G.M.

AU - Bootsma, Hendrika

PY - 2018/6/18

Y1 - 2018/6/18

N2 - Sjögren’s syndrome (SS) is an autoimmune inflammatory disorder of the exocrine glands, particularly affecting lacrimal and salivary glands. Hallmark symptoms are dry mouth and dry eye, often in conjunction with general symptoms, such as malaise and fatigue. Lymphomas could develop in 5–10% of the patients. As SS is a rather complex syndrome with many features, the one patient being diagnosed with SS may suffer from a different complex of complaints than another SS patient and may thus be in need of a different treatment approach. To better classify SS patients and to personalize their treatment, many clinicians and researchers are currently working on efforts (1) to refine classification of SS patients, (2) to ease the diagnostic work-up of SS, and (3) to better understand the etiopathogenesis of SS. Latter knowledge is essential to understand the course of the disease. This way clinicians will be able to identify patients who are at risk of developing SS or lymphomas; can intervene at an early stage of the disease to prevent damage to, e.g., the glands; as well as can personalize treatment with, e.g., biologicals. In this chapter, current major achievements are discussed, and promising new directions are indicated.

AB - Sjögren’s syndrome (SS) is an autoimmune inflammatory disorder of the exocrine glands, particularly affecting lacrimal and salivary glands. Hallmark symptoms are dry mouth and dry eye, often in conjunction with general symptoms, such as malaise and fatigue. Lymphomas could develop in 5–10% of the patients. As SS is a rather complex syndrome with many features, the one patient being diagnosed with SS may suffer from a different complex of complaints than another SS patient and may thus be in need of a different treatment approach. To better classify SS patients and to personalize their treatment, many clinicians and researchers are currently working on efforts (1) to refine classification of SS patients, (2) to ease the diagnostic work-up of SS, and (3) to better understand the etiopathogenesis of SS. Latter knowledge is essential to understand the course of the disease. This way clinicians will be able to identify patients who are at risk of developing SS or lymphomas; can intervene at an early stage of the disease to prevent damage to, e.g., the glands; as well as can personalize treatment with, e.g., biologicals. In this chapter, current major achievements are discussed, and promising new directions are indicated.

U2 - 10.1007/978-3-319-78205-8_10

DO - 10.1007/978-3-319-78205-8_10

M3 - Chapter

SN - 978-3-319-78204-1

SP - 123

EP - 141

BT - Translational Oral Health Research

A2 - Meurman, Jukka H.

PB - Springer International Publishing

ER -

ID: 79452287